American Society of Hematology

Minority Medical Student Award Recipients

The following students have participated in the ASH Minority Medical Student Award Program (MMSAP).

2018 Participants

  • Ijele Adimora
    The Geisel School of Medicine at Dartmouth
    Assessing risk of post-operative bleeding complications around heparin bridging protocol intervention
  • Jennifer Afranie-Sakyi
    Chicago Medical School at Rosalind Franklin University of Medicine & Science
    The role of ineffective mitophagy and mitophagy-inducing agents on sickle cell disease
  • Rachel Alade
    Frank H. Netter School of Medicine Quinnipiac University
    Identifying risk factors associated with high medical resource utilization in adolescents and young adults with sickle cell disease
  • Anase Asom
    Pritzker School of Medicine at The University of Chicago
    The role of BRCA1 in genomic instability and hematopoietic malignancies
  • Rita Asuquo
    Central Michigan University College of Medicine
    Enhancing the anti-tumor activity of off-the-shelf Epstein–Barr virus (EBV) -specific T cells for treatment of EBV+ lymphoma
  • Lissa Bair
    University of Ottawa Faculty of Medicine
    Reassessing the need for pre-operative transfusions in sickle cell disease patients with a high baseline hemoglobin
  • Mauricio Barreto
    University of North Carolina School of Medicine
    Clinical investigation of cytokine levels in patients with sickle cell disease undergoing haploidentical nonmyeloablative hematopoietic stem cell transplantation
  • Elizabeth De Jesus
    Tufts University School of Medicine
    Inherited thrombophilias and the risk of ischemic stroke in adults: A systematic review and meta-analysis
  • Atinuke "Oyin" Dosunmu-Ogunbi
    University of Pittsburgh School of Medicine
    Oxidative stress and neurocognitive dysfunction in sickle cell disease
  • Ista Egbeto
    Tufts University School of Medicine
    Understanding the cooperative impact of BCOR and U2AF1 mutations in myelodysplastic syndrome pathogenesis
  • Tolulope Fatola
    Meharry Medical College
    Understanding the difference between clinical trials participants and real-world patients treated for mantle cell lymphoma, diffuse large B-cell lymphoma and follicular lymphoma
  • Aldo Giaimo
    University of Cincinnati College of Medicine
    Exploring the impact of germline mutations on the differentiation of mesenchymal stromal cells into osteocytes
  • Catherine Gutierrez
    Harvard Medical School
    Studying cancer evolution in chronic lymphocytic leukemia using DNA barcode-assisted lineage tracing
  • Naima Hashi
    The Ohio State University College of Medicine
    Cytomegalovirus modulation of miR-29b expression in natural killer cells in acute myeloid leukemia
  • Nathanaelle “Onyi” Ibeziako
    Tufts University School of Medicine
    BCL11A enhancer editing for the hemoglobinopathies
  • Sophia LeMaire
    Howard University College of Medicine
    Ancestry and genetic admixture mapping for red blood cell antigen alloimmunization in adults with sickle cell disease
  • Randolph Lyde, Jr., PhD
    Temple University School of Medicine
    Comparative analyses of platelet factor VIII expression by standard bone marrow transplantation versus intraosseous infusion
  • Christina Marcelus
    State University of New York Upstate Medical University
    Characterization of TRK fusions and response to TRK inhibition in hematologic malignancies
  • Jacqueline Mercado
    Michigan State University College of Human Medicine
    Stimulating translational output in diamond blackfan anemia by targeted inhibition of NLK
  • Pascal Merritt
    Indiana University School of Medicine
    Role of CXCR1 and CXCR2 in cell-cell aggregation in micro-vessels of sickle cell disease mice
  • Mubarik Mohamed
    The Ohio State University College of Medicine
    Immune checkpoint molecule expression in acute myeloid leukemia
  • Chibuikem Nwizu
    Warren Alpert Medical School at Brown University
    Vesicle initiation of leukemia phenotype in normal adult bone marrow
  • Oluwaseun "Seun" Orikogbo
    University of Pittsburgh School of Medicine
    Role of hemopexin in acute kidney injury of sickle cell disease during hemolytic crisis
  • Derrick Ridley
    Emory University School of Medicine
    Elucidating the role of comorbidity in patients with mantle cell lymphoma
  • Anjelica Saulsberry
    University of Tennessee Health Science Center College of Medicine
    Transition readiness and cognition as predictors of optimal transition to adult care in patients with sickle cell disease
  • Kekoa Taparra, PhD
    Mayo Clinic School of Medicine
    Bleomycin use in the treatment of hodgkin lymphoma: changes over the years
  • Ammanuel Taye
    Howard University College of Medicine
    Orosomucoid as a biomarker for chronic kidney disease associated with sickle cell disease
  • Ashley Thrower
    University of North Carolina School of Medicine
    The effect of opioid analgesics on albuminuria in adult patients with sickle cell anemia
  • Vanessa Vides
    Pennsylvania State College of Medicine
    Correlative studies on a clinical trial of Anti-CD19 chimeric antigen receptor T cells in combination with ibrutinib for patients with chronic lymphocytic leukemia
  • back to top

    2017 Participants

    • Alexandra Boye-Doe
      Case Western Reserve University School of Medicine
      Red cell adhesion in adult patients with sickle cell disease, at baseline and with pain, measured on a microfluidic device
    • Jeffrey Edwards
      Stanford University School of Medicine
      Targeted inhibition of CREB for the treatment of pediatric acute myeloid leukemia
    • Moses Evbuomwan
      Oakland University William Beaumont School of Medicine
      Evaluating new VLA-4 inhibitors with gro-ßt to mobilize hematopoietic stem cells/progenitors cells
    • David Foreman
      Medical College of Georgia at Augusta University
      miR-15a mediated MYB gene silencing: a novel approach to induce fetal hemoglobin
    • Lilian Iglesias
      Case Western Reserve University School of Medicine
      Long-term outcomes of chronic myeloid leukemia patients in the United States – Evolving risk of second cancers and survival trends
    • Austin Ikechi
      The Ohio State University College of Medicine
      Patterns of disease relapse and progress after therapy in patients with multiple myeloma treated with daratumumab
    • Marjorie Johnson
      Medical College of Georgia at Augusta University
      Development of the novel prodrug conjugate of butyrate and delta-aminolevunate for treatment of sickle cell disease
    • Ramanjot Kang
      Wright State University Boonshoft School of Medicine
      The development of autoimmune diseases in women with pregnancies affected by fetal-neonatal alloimmune thrombocytopenia
    • Orly Leiva
      Boston University School of Medicine
      Mechanisms of control of lysyl oxidase expression in JAK2-mutated myelofibrotic cells
    • Lanair Lett
      Perelman School of Medicine at the University of Pennsylvania
      Investigating health disparities in infection among pediatric patients with acute leukemia
    • Christina Marcelus
      State University of New York Upstate Medical University
      Identifying mechanisms of resistance to spliceosomal inhibitors for spliceosomal mutant leukemias
    • Christopher Miller
      Chicago Medical School of Rosalind Franklin University of Medicine and Science
      Testing if TET3 is a direct HIF target during erythropoiesis
    • Lillian Nwanah
      University Of Illinois College of Medicine
      DREAM-regulated PI3K activity in platelet function and thrombosis
    • Violeta Osegueda
      University of California, Irvine School of Medicine
      Assessing transfusion protocol for adult patients with suspected brain bleeds in a MTP-like protocol vs standard care
    • Wilton Robinson, Jr.
      Georgetown University School of Medicine
      Predictors of treatment outcomes for relapsed diffuse large B-cell lymphoma patients
    • Anjelica Saulsberry
      University of Tennessee Health Science Center College of Medicine
      Disease knowledge and self-management skills among adolescents with sickle cell disease
    • Jasmine Smith
      University of South Carolina School of Medicine Greenville
      Hematopoietic stem cell transplant and sickle cell disease: how to maximize use of this curative therapy
    • Cristian Taborda
      Columbia University College of Physicians and Surgeons
      Role of microbiome diversity in shaping the graft-versus-host immune response after allogeneic hematopoietic stem-cell transplantation
    • Roberto Tapia
      Rush Medical College
      Correlative studies to examine the effects of Alisertib therapy in patients with myelofibrosis
    • Allison Taylor
      Georgetown University School of Medicine
      Analyzing the antigen expression profile on multiple myeloma cells for CAR T-cell therapy
    • Maria Torres
      Mayo Clinic School of Medicine
      Impact of hospitality houses on the quality of life and mood of hematopoietic stem cell transplant patients and caregivers
    • Monica Williams
      The Ohio State University College of Medicine
      Characterizing PD-1 expression on NK cells in HLA-matched hematopoietic stem cell transplant: impact on clinical outcomes
    back to top

    2016 Participants

    • Tokunbo Adeniyi
      University of Illinois at Chicago College of Medicine
      Life beyond sickle cell disease post-transplant: adults with SCD who had an AlloHSCT and their health-related quality of life
    • Moriyike Akinosun
      University of Illinois at Chicago College of Medicine
      The exercise genomics study
    • Kelsey Chatman
      The Ohio State University College of Medicine
      Evaluation of combination epigenetic therapeutics in mantle cell lymphoma
    • Austin Ikechi
      The Ohio State University College of Medicine
      Post pain symptoms in transplant patients with sickle cell disease
    • Ramanjot Kang
      Wright State University Boonshoft School of Medicine
      The development of autoimmune diseases following HPA-1a alloimmunization in fetal-neonatal alloimmune thrombocytopenia (FNAIT)
    • Serina Lewis
      Georgetown University School of Medicine
      Utilizing pathology informatics for subtyping diffuse large B-cell lymphoma
    • Heardley Murdock
      Perelman School of Medicine at the University of Pennsylvania
      Investigating DNA methylation to predict outcome in secondary acute myeloid leukemia
    • Arinze Nwokeji
      The Ohio State University College of Medicine
      Identifying NuRD subunit protein domains Necessary for γ-globin Silencing
    • Israel Orta
      Albert Einstein College of Medicine
      The role of red blood cell (RBC) endogenous nitric oxide production as a link between sickle cell RBC and vascular disease
    • Violeta Osegueda
      University of California
      Effectiveness of tier platelet protocol implementation for critical intracranial hemorrhage
    • Yasmin Rawlins
      Columbia University College of Physicians and Surgeons
      Racial and ethnic differences in toxicities of childhood ALL therapy
    • Gabriel Washington
      Stanford University
      Analysis of red blood cells after in vitro differentiation of HBB edited hematopoietic stem and progenitor cells
    • Monica Williams
      The Ohio State University College of Medicine
      Elucidation of immune evasion by acute myeloid leukemia
    • Carolyn Wright
      Perelman School of Medicine at the University of Pennsylvania
      Defining the optimal approach for discontinuing plasma exchange in patients with acquired thrombotic thrombocytopenic purpura
    back to top

    2015 Participants

    • Felicia M. Austin
      Howard University College of Medicine
      GTP Cyclohydrolase 1 (GCH1) gene polymorphism as a marker for experimental functional pain in sickle cell anemia
    • Taisha Doo
      University of Iowa Carver College of Medicine
      Effect of type 2B von Willebrand disease ADAMTS13 cleavage products on platelet binding
    • Odianosen Eigbire-molen
      Georgetown University
      Volumetric brain changes in sickle cell disease: effect of chronic transfusion therapy
    • Sean Fletcher
      Harvard Medical School
      Characterizing hospice use among patients with myelodysplastic syndromes
    • Samantha Glass
      University of Illinois at Chicago
      Racial inequality in patients with diffuse large B-cell lymphoma
    • Tyler Hyman
      The Ohio State University College of Medicine
      Modulating transcription to assess natural killer cell function against acute myeloid leukemia
    • Jolene Kokroko
      University of California – San Francisco
      Genetic modifiers of sickle cell anemia severity
    • Katerina Konstantinoff
      Washington University School of Medicine
      Investigating the role of bone marrow sinusoidal pericytes in the stem cell niche and HSC maintenance
    • Kelli Currie
      Meharry Medical College
      Risk of cerebral infarcts recurrence associated with acute drop in hemoglobin levels: SIT trial cohort analysis
    • Rigoberto De Jesús Pizarro
      University of Puerto Rico
      Characterization of the DNA damage response induced by vosaroxin and azacitidine and correlation with clinical response
    • Tolulope Rosanwo
      Case Western Reserve University School of Medicine
      SCD biochip: Towards a simple and reliable way to monitor sickle cell disease
    • Louis Rucker
      The Ohio State University College of Medicine
      Exploration of pharmaceutical treatment of sickle cell disease using novel high-throughput assay
    • Nicole Yordán-López
      University of Puerto Rico Medical Sciences Campus
      Investigating the structural basis of PP2A activation by perphenazine for high-risk T-cell acute lymphoblastic leukemia
    back to top

    2014 Participants

    • Ambrose Campell
      Saint Louis University
      Effect of Continuous CXCR4 Blockade on Leukemic Stem Cell Mobilization and Chemosensitization
    • Odianosen Eigibre-Molen
      Georgetown University
      FMRI as a tool for pain assessment in Sickle Cell Disease
    • Ismanie Guillaume
      The George Washington University School of Medicine and Health Sciences
      Limits of Non-African Genetic Admixture Flanking the Sickle Mutation in an Admixed SCD Population
    • Itamar Niesvizky-Kogan
      SUNY Upstate Medical University
      MLL Function in Follicular Lymphoma Oncogensis
    • Jordan Paul Cole
      The Ohio State University School of Medicine
      Modulation of natural killer cell maturation in the context of acute myeloid leukemia
    • Monica L. Mitchell
      The Ohio State University School of Medicine
      Adoptive CTL Therapy to Treat EBV-Driven Lymphomas
    • Nicholas Hampilos
      Perelman School of Medicine at the University of Pennsylvania
      Effect of donor cell targeted delivery of GSK3B inhibitor by liposome-based nanoparticles on hematopoietic engraftment following in utero transplantation
    • Olusola Laja
      Meharry Medical College
      The role of FGF23 in sickle disease cell kidney disease and cardiac hypertrophy
    • Reinaldo Perez
      Perelman School of Medicine at the University of Pennsylvania
      The effect of specific TRAF subtype overexpression on the activity, proliferation and survival of chimeric antigen receptor T cells.
    • Ruth Jocelyn Claros
      Wright State University Boonshoft School of Medicine
      Analysis of Adherence to Mercaptopurine in Asian Children with ALL
    • Shimena Li
      University of North Carolina School of Medicine
      Leucine-Rich α-2 Glycoprotein (LRG): A potential novel neutrophil granule protein
    • Tyler-Lauren Rainer
      Temple University School of Medicine
      Induced Hematopoietic Stem Cell Exhaustion in Dyskeratosis Congenta Model through Stressing Bone Marrow
    back to top

    2013 Participants

    • Gilbert M. Acevedo
      University of Colorado School of Medicine
      Role of Axl FC in platelet inhibition
    • Hewan Belete
      University of Minnesota (Second-year participant)
      Predicting transplantation-related toxicity in older adults following HCT
    • Aleshia Nichol Brewer-Lowry
      Chicago Medical School
      Recurrent Brain Injury in Adults with SCD and Stroke
    • Miguel Dario Cantu
      The University of Texas Medical School at Houston
      Determination of signature protein classifiers of high-rish langerhans cell histiocytosis and relapse in pediatric and adult plasma samples
    • Denzel Cole
      Morehouse School of Medicine
      Dissecting the mechanisms regulating endogenous immune regeneration
    • Sophia Harvey
      Michigan State University College of Human Medicine
      Natural killer cell development in acute myeloid leukemia
    • Sarafina Kankam
      University of Kansas School of Medicine
      Decreasing Hospital Readmission Among Children with Sickle Cell Disease: The Impact of the Medical Home
    • Karen C. Manotas
      The University of Utah
      Long and short term outcomes of alloimmune thrombocytopenic mothers and neonates treated with IVIG 2x/week + prednisone treatment plan and no antenatal blood sampling
    • Reilin J. Moore
      Indiana University
      The effect of CD26/DPP 4 on the functional activity of MIP-1ᾱ for inhibition of proliferation of hematopoietic profenitor cells
    • Joy Morgan
      Howard University College of Medicine
      MicroRNA expression profiles in sickle cell disease
    • Jamaji Nwanaji-Enwerem
      Harvard Medical School
      Creating a mammalian erythroid cell line to biochemically charaterize sideroflexin-4 and it role in megaloblastic anemia and mitochondrial disease
    • Osarhiemen Omwanghe
      University of Illinois at Urbana-Champaign
      Hibitual physical activity and exercise patterns in children with sickle cell disease
    • Manuel Ozambela
      Harvard Medical School
      Use of glycotransferase-programed stereosubsitution (GPS) to improve targeted stem cell therapies in rodel model of traumatic brain injury
    • Lauren Patrick
      University of Rochester School of Medicine and Dentistry
      The role of bone marrow stroma in acute lymphoblastic leukemia cell dormacy during maintenance chemotherapy
    • Necrisha Roach
      The Ohio State University College of Medicine
      Targeting the PRMT5 Enzyme in Sickle Cell Anemia
    back to top

    2012 Participants

    • Jeneba Abass-Shereef
      UMDNJ-Robert Wood Johnson Medical School
      Targeting self-renewal pathways regulating Mantle Cell Lymphoma-Initiating Cells
    • Rhae Battles
      Meharry Medical School
      Role of the Elf2 Transcription Factor in Erythroid Gene Expression and Terminal Differentiation
    • Hewan Belete
      University of Minnesota
      The role of omega-3 fatty acids can in hematopoietic cell transplantation patients with sirolimus induced hyperlipidemia
    • Ryanne Ashley Brown
      Baylor College of Medicine
      Identification of the enzymes involved in the VWF-GPIba binding-initiated
    • Guensley Delva
      UMDNJ-Robert Wood Johnson Medical School
      Targeting MLL-AF9 fusion protein with PARP inhibitors
    • Laurette Femnou
      Johns Hopkins University
      Evaluation of the effect of sodium salicylate on inflammation and iron homeostasis in aged mice
    • William Courtland Lewis
      The Ohio State University College of Medicine
      Analysis of Mll-PTD function in the absence of Mll-WT in adult murine bone marrow
    • Michelle Long
      Wake Forest University School of Medicine
      Complex Pediatric Hematology Consults: Immune Cytopenial Following Liver and Multivisceral Transplants
    • Shannalee Rene Martinez
      Loma Linda University
      Evaluation of Juvenile Myelomonocytic Leukemia (JMML) cell sensitivity to Natural Killer (NK) cell-mediated lysis in the presence and absence of epigenetic sensitization
    • Myntee T. Ngangana
      The Ohio State University
      Assessment of Hematopoietic Stem Cell Transplantation Comorbidities Index in DNMT3A and Flt3-ITD AML Patients Receiving Decitabine
    • Ifeanyi Nzegwu
      University of Cincinnati College of Medicine
      The role of cytokines and toll like receptor 4 in acute chest syndrome
    • Elisa Quiroz
      Ponce School of Medicine
      Characterize the expression patterns of NP-9 and Rec in HERV-K (HML2)-expressing cells
    • Lynda Villagomez
      Albert Einstein College of Medicine of Yeshiva University
      Evaluating a novel class of drug targeting PRMT5 enzyme dysregulation in mantle cell lymphoma
    • Tatiana Melissa Villatoro
      San Juan Bautista School of Medicine
      Progression of Vasculopathy in Children with Sickle Cell Disease and Abnormal Transcranial Doppler Ultrasonography: Rates and Predictors
    back to top

    2011 Participants

    • Oyinade Aderibigbe
      University of Pennsylvania School of Medicine
      The clinical course and severity of viral illness in pediatric patients with sickle cell disease
    • Ryanne Brown
      Baylor College of Medicine
      Characterization of the VWF-GPIbα binding-initiated signaling pathway that results in platelet activation and fibrin(ogen)-αIIbβIII interaction under high shear stress
    • Nicole Diaz
      University of Illinois at Chicago College of Medicine
      Cell line model of refractory anemia with ringed sideroblasts developed through inappropriate iron accumulation by silenfcing of iron processing genes
    • Hyunjoo Lee
      Stony Brook University College of Medicine
      Effect of polymorphisms in p53 pathway proteins and chronic lymphoid leukemia disease progression
    • Ko Maung
      East Tennesse State University, Quillen College of Medicine
      Structural requirements of LDB1 function in erythroid differentiation
    • Lilian Msambichaka
      University of Minnesota Medical School
      Characteristics and mechanism of pain in sickle cell disease
    • Maura Munoz
      The Ohio State University College of Medicine
      In vitro studies of a new Bortezomib formulation against acute myeloid leukemia
    • Steven Ovu
      Texas A&M Health Science Center - College of Medicine
      Study of the clinical practice guidelines for prevention and treatment of acute chest syndrome in sickle cell disease
    • Yakisha Partee
      Meharry Medical College
      Mitochondrial DNA mutations in sickle cell disease
    • Christopher Rombaoa
      Tufts University School of Medicine
      Characterization of microRNA-393 and -494 in the biology of Waldenstrom Macroglobulinemia
    • Debora Zamora-Olivencia
      San Juan Bautista School of Medicine
      Evaluation of safer lentivirus vectors for a successful sickle cell disease gene therapy
    back to top

    2010 Participants

    • Imo Akpan
      University of Illinois at Chicago
      Determination of the manner in which changes within the γ-globin gene are linked to differences in histone H3 (lys9) methylation following decitabine administration in the baboon model
    • Tiana Carrillo
      University of Illinois at Chicago
      Iron-mediated ROS production as a mechanism for RARS and the basis for therapeutics
    • May Cho
      Meharry Medical College
      Structural requirements of LDB1 function
    • Drees Griffin Jr.
      University of Alabama School of Medicine
      Creation of the UAB thrombotic thrombocytopenic purpura-hemolytic uremic syndrome registry
    • Tiffany D. Jackson
      Mercer University School of Medicine
      Production of erythrocytes from human embryonic stem cells
    • Courtney Nicole Johnson
      University of Southern California, Keck School of Medicine
      Disease knowledge in chronic myelogenous leukemia patients as a predictor of compliance to treatment
    • Michelle Long
      Wake Forest University School of Medicine
      Pediatric immune thrombocytopenic purpura: drug treatments and responses
    • Myntee Ngangana
      The Ohio State University College of Medicine
      Association between epigenetic changes and acute myeloid leukemia
    • Jennifer Nichols
      University of Illinois at Chicago
      The effects of environmental cues and differentiation state on hematopoietic stem cell colony growth, morphology, and fetal hemoglobin production
    • Kandyce Pearson
      University of Iowa
      Characterization of K13-NEMO interaction
    • Stacey Pereira
      Rush Medical College
      Kinetics of engraftment: single-donor dominance versus dual-donor chimerism in double cord blood transplant outcomes
    • Pablo N. Quintana
      University of Illinois at Chicago
      Targeting miRNAs that regulate the glucocorticoid receptor as a potential therapeutic for multiple myeloma
    • Vanessa Sarfoh
      University of Buffalo School of Medicine and Biomedical Sciences
      Magnetic resonance imaging of liver and cardiac iron
    • Ngozidilenna Wilkins
      University of Arkansas for Medical Sciences
      Characterization of platelet α-granule dynamics
    back to top

    2009 Participants

    • Nnenaya Agochukwu
      Louisiana State University School of Medicine, Shreveport, LA
      Objective Measure of Pain During Sickle Cell Pain Crisis
    • Mohamad Alghothani
      University of Illinois, Champaign-Urbana College of Medicine, Urbana, IL
    • Imo Akpan
      University of Illinois at Chicago College of Medicine, Chicago, IL
      Determination of the Manner that Changes Within the γ-globin Gene are Linked to Differences in Histone H3 (lys9) Methylation Following Decitabine
    • Jamie Brewer
      University of Illinois at Chicago College of Medicine, Chicago, IL
      Significance of Factor VIII Inhibitors in Hemophilia A Patients
    • May Cho
      Meharry Medical College, Nashville, TN
      Structural Requirements for LDB1 Protein Dimerization in Mammalian Cells
    • Hector R. Flores-Bermudez
      Universidad Central del Caribe - School of Medicine, Bo Bayamon, PR
      Activation of PP2A as a Therapeutic Target in Multiple Myeloma
    • Ashanti Franklin
      University of Southern California, Keck School of Medicine, Los Angeles, CA
      Elucidating the Affects of PIGA Gene Mutation in Endothelial Cells in ParoxysmalNocturnal Hemoglobinuria
    • Michael Garcia
      Harvard Medical School, Boston, MA
      Elucidating the Molecular Mchanism of CD74 Aoptosis Ihibition in Lmphoma
    • William J. Gostic II
      Harvard Medical School, Boston, MA
      A Comparison of Myelosuppression in Pediatric ALL Treatment Using PEG‐asp and L‐asp
    • Tiffany D. Jackson
      Mercer University School of Medicine, Macon, GA
      Production Erythrocytes from Human Embryonic Stem Cells
    • Courtney Nicole Johnson
      University of Southern California, Keck School of Medicine, Los Angeles, CA
      Disease Knowledge in Chronic Mylogenous Leukemia Patients as a Predictor of Complaince to Treatment
    • Steven Ovu
      Texas A&M Health Science Center - College of Medicine, College Station, TX
      Investigating the Important Role of Nucleonin in SLL/CLL Apoptosis
    • Vanessa Pineros
      University of Pennsylvania, Philadelphia, PA
      Targeting the c-Myb mRNA: A Novel Approach to Treating Acute Leukemia
    • Nneamaka Ugbode
      Jefferson Medical College, Philadelphia, PA
      Manipulating the Stability of β-globin mRNA for the Treatment of Major Hemoglobinopathies
    • Elizabeth Yeboah
      University of Toronto, Toronto, ON
      Determining the Patient and Disease Characteristics that Correlate with Long-term Reponse to Lenalidomide in the Treatment of Relapsed Multiple Myeloma
    back to top

    2008 Participants

    • Awet Abraha
      Wayne State University, Detroit, MI
      Retargeting Cord Blood T Cells to Provide Anti-Lymphoma Effects After Stem Cell Transplant
    • Olabunmi Agboola
      University of Illinois at Chicago, Chicago, IL
      Examining the Factors Influencing Sickle Cell Patient's Decision Making Regarding Transplantation
    • Nnenaya Agochukwu
      Louisiana State University, Shreveport, LA
      Assessing Objective Parameters of Pain in Patients With Sickle Cell Anemia
    • Jamie Brewer
      University of Illinois at Chicago, Chicago, IL
      Determining the Prevalence of Factor VIII Inhibitor by ELISA Assay in Patients With a Negative Bethesda Assay
    • Andres Bur
      University of Pennsylvania, Philadelphia, PA
      Studies Measuring Platelet Accumulation on Collagen and Stability Flow in a Microfluidics Chamber
    • Daniel Hayward
      Jefferson Medical College, Philadelphia, PA
      Pain and Other Complications of Sickle Cell Disease in Patients With SB+Thalassemia: Rates and Risk Factors
    • Candace Johnson
      Wayne State University, Detroit, MI
      Chart Review Study to Evaluate Possible Effects of Opiods on Blood Vessel Formation in Patients With Sickle Cell Disease
    • Nicole Jones
      Wayne State University, Detroit, MI
      The Membrane Scavenger Receptor, CD36 and the MpL-Baltimore Polymorphosime
    • Christina Lawson
      Howard University, Washington, DC
      Preclinical Trial of Nitrite-Treated Transfused RBC and Dietary Supplementation
    • Edward E. Robertson
      University of Southern California, Los Angeles, CA
      Challenging the Epigenetic Paradigm: DNA Methylation Analysis of Philadelphia Chromosome Associated Leukemia
    • Akram Shayeb
      University of Puerto Rico, Urb Altamesa, PR
      Significance of Mitochondrial Localization of Mitochondrial Antiviral Signaling (MAVS) in the Antiviral Defense Against Coxsackievirus B3 (CVB3) Infection
    • April Szafran
      University of Illinois at Chicago, Chicago, IL
      Identification of a Gene or Genes on Chromosome 16q22 that may be Linked to the Development of Familial Acute Myeloid Leukemia
    • Nadine Thompson
      Virginia Commonwealth University, Richmond, VA
      Investigating Cell Cycle-Related Factors Triggering Apoptosis in Human Leukemia Cells
    back to top

    2007 Participants

    • Awet Abraha
      Wayne State University School of Medicine, Detroit, MI
      Investigation of Alternate NK Cell Developmental Pathway
    • Olabunmi Agboola
      University of Illinois at Chicago College of Medicine, Chicago, IL
      Developing Tools for Assessing Time-Tradeoff Utilities Multidimensional Survey to Assess Quality-of-Life for Patients with Lymphoma
    • Abisola Ayodeji
      Virginia Commonwealth University School of Medicine, Richmond, VA
      The Role of the Hypoxic Response and the Hypoxic Inducible Factor Related Genes in Sickle Cell Anemia and in Congenital Polycythemia with Upregulated Hypoxic Sensing
    • Luz Juliana Barahona
      Universidad Central del Caribe SOM, Bayamon, PR
      T-Cell Subsets and Graft vs. Tumor Effect in Stem Cell Transplantation
    • Melissa Bent
      Morehouse School of Medicine, Atlanta, GA
      Effect of TGF-B1 Treatment on the Expression of a-Smooth Muscle Actin by Sickle Cell and Normal Endothelial Progenitor Cells (EPCs)
    • Johnaca Biggins
      Ohio State University College of Medicine, Columbus, OH
      HOXB7 Protein as a Prognostic Factor in Chronic Lymphocytic Leukemia
    • Ashanti Franklin
      University of Southern California Keck School of Medicine, Los Angeles, CA
      Examining Novel Methods of Gene Delivery to Human Hematopoietic Stem Cells
    • Nicole Jones
      Wayne State University School of Medicine, Detroit, MI
      Expression of the CD36 and Pevalence of Mpl Baltimore and Their Relationship to Stroke in Pediatric Sickle Cell Patients
    • Johnathan J. Ledet
      Louisiana State University School of Medicine, Shreveport, LA
      In Vitro Study of the TXNIP/TRX/ROS Activity in a Series of Cell Lines Derived from B and T-Cell Lymphomas Treated With the Histone Deacetylase Inhibitor Vorinostat in Combination with Various Other Drugs
    • Emily McElveen
      Brown Medical School, Providence, RI
      Do Sickle Cells Stimulate NO Production Via ATP Release in a Manner Similar to Normal Red Blood Cells?
    • Jennifer Robles
      Case Western Reserve University School of Medicine, Cleveland, OH
      Defining Mechanisms of Resistance to TSP-Mediated Anti-Angiogenesis, Focusing Specifically on CD36 Down-Regulation in Cultured Microvascular Endothelial Cells.
    back to top

    2006 Participants

    • Christina Bennett
      Indiana University School of Medicine, Indianapolis, IN
      Trends in Leukemia Incidence in California: 1988-1999
    • Fernando Diaz
      Instituto Tecnologico y de Estudios Superiores de Monterrey, Katy, TX
      Platelet Hyperreactivity in Sickle Cell Patients
    • Robert George Eberhardt
      University of Pennsylvania School of Medicine, Philadelphia, PA
      Investigation of Gamma Fibrinogen Levels and Thrombus Formation Using the Mouse Cremaster Arteriole/Venule Laser Injury Model
    • Qurana Lewis
      Oklahoma State University School of Medicine, Tulsa, OK
      Do Patients Have Cognitive Impairment Following Recovery from Thrombotic Thrombocytopenic Purpura (TTP)?
    • Josiah Orina
      Emory University School of Medicine, Decatur, GA
      Comprehensive Meta-Analysis of the Benefits of Rituximab and Chemotherapy for Patients With Untreated Follicular Lymphoma
    • Mary Rickard
      University of Iowa College of Medicine, Iowa City, IA
      A Genome-Wide Scan of a Large Amish Pedigree With von Willebrand Disease Identified Regions of Linkage that Represent Potential Modifiers of Von Willebrand Factor Levels and Disease Variability
    • Margo Renee Rollins
      Rush Medical College, Chicago, IL
      Patulin: A Small Molecule Mycotoxin Possessing Potent Selective In Vitro Cytotoxicity Against Malignant T-Cells
    • Naa Sackey
      Drexel University College of Medicine, Philadelphia, PA
      Identification of Striatin as a Microtubule-Associated Protein in Human Platelets
    • Melody Smith
      University of Texas Southwestern, Dallas, TX
      Mechanism for the Immunosuppressive Activity of Pentostatin: Selective Apoptosis of Naïve T-Cell Subsets
    back to top

    2005 Participants

    • Demedrick Anton Bland
      Boston University School of Medicine, Boston, MA
      Determining the Role of Nitric Oxide Bioavailability and Genetic Polymorphisms in the Pathogenesis of Pulmonary Hypertension in Sickle Cell Disease Patients
    • LaRae Coleman
      University of Florida College of Medicine, Gainesville, FL
      Transfusion Management in Sickle Cell Disease: Assessment of Physician Prescribing Practices
    • Nkiruka Emeagwali
      Meharry Medical College, Nashville, TN
      Mutations in Mitochondrial DNA and Oxidative Stress in Children With Sickle Cell Anemia
    • Delwin S. Merchant
      Case Western Reserve University School of Medicine, Shaker Heights, OH
      In Vitro Megakaryocytopoiesis in Idiopathic Myelofibrosis
    • Josiah Orina
      Emory School of Medicine, Atlanta, GA
      Determining the Benefits of Chemotherapy for Achieving Complete Response in Patients With Untreated Advanced-Stage Follicular Lymphoma: A Systematic Review and Meta-Analysis
    • Oscar Penate
      University of Washington School of Medicine, Seattle, WA
      Survival of Normal and Mutant CXCR4-Transfected HL-60 Cells in Myelokathexis
    • Joseph W. Smith
      University of Louisville School of Medicine, Louisville, KY
      Evaluation of the In Vitro Activity of the Multikinase Inhibitor BAY 43-9006 (Sorafenib) in Primary Cells from Patients With Myelofibrosis With Myeloid Metaplasia
    • Melody Smith
      University of Texas Southwestern School of Medicine, Dallas, TX
      Ex Vivo Fludarabine Selectively Depletes Human Naïve T-Cell Subsets: A Step Toward Modifying Donor Lymphocyte Infusion
    back to top

    2004 Participants

    • Allison Cole
      Northwestern University, Feinberg School of Medicine, Chicago, IL
      HOXA11 Impairs Megakaryocytic Differentiation in K562 Cells
    • Edna Chavez
      University of Iowa College of Medicine, Iowa City, IA
      Genetic Linkage in a Large Pedigree With von Willebrand Disease
    • Nkiruka Emeagwali
      Meharry Medical College, Nashville, TN
      Mitochondrial DNA and Sickle Cell Anemia
    • Luciana Guerra
      Mount Sinai School of Medicine, New York, NY
    • Doreen Kyere
      University of Maryland School of Medicine, Baltimore, MD
      Evaluate the Structural Features of mRNA that Encode Gamma-Globin and Provide it With its Exceptional Stability in Differentiating Erythroid Cells
    • Leonard Mason
      Temple University School of Medicine, Philadelphia, PA
      The Clinical Course of HCV and HBV in Heart Transplant Recipients
    • Oscar Penate
      University of Washington School of Medicine, Seattle, WA
      Aberrant Mitochondrial Cytochrome C Release in Congenital Neutropenia
    • Candice Taylor
      University of Southern California, Keck School of Medicine, Los Angeles, CA
      The Effect of Hydroxyurea on PLGF Production in Erythroid Cells
    • Deborah Titre
      Howard University College of Medicine, Washington, DC
      Identifying Mutations in Genes Involving Hematopoiesis in the Zebrafish Using Reverse Genetics
    • Gus Zamora
      University of Texas Health Science Center at Houston Medical School, Houston, TX
      Quantitative Real Time PCR of G-CSF Receptor Isofoms and Associated Molecule Gab2
    back to top